SALIX PHARMACEUTICALS
| WVB Number: 33118NU | Country: United States of America |
| SIC categorization: PHARMACEUTICAL PREPARATIONS (2834) | ISIN: US7954351067 |
| FT categorization: DRUGS (433) |
» Corporation Profile
| Profile in brief: The Company engages in the acquisition, development, and commercialization of prescription drugs used in the treatment of various gastrointestinal diseases, which are those affecting the digestive tract. |
|
| Phone: 1 919 862 1000 | Fax: 919 862 1095 |
| Chairman: JOHN F. CHAPPELL | Auditor: ERNST & YOUNG LLP |
| CEO/Managing Director: CAROLYN J. LOGAN | |
» Company Facts
| Net Profit Margin (%) | 3.49 |
| Operating Margin (%) | 6.44 |
| Return on Assets (%) | 2.28 |
| Return on Equity (%) | 2.89 |
| Employees | 270 |
» Company Financials
| Annual (2007) | |
| Income Statement ('000 USD ) |
|
| Sales/Total Revenue | 235,792 |
| EBITDA | 22,494 |
| EBIT | 11,852 |
| Net Income | 8,225 |
| Balance Sheet ( '000 USD) |
|
| Total Current Assets | 195,375 |
| Total Assets | 397,102 |
| Total Current Liabilities | 86,484 |
| Total Liabilities & Debt | 104,532 |
| Total Equity | 292,570 |
| Cash Flow ( '000 USD) |
|
| Net Income/Starting Line | 8,225 |
| Cash from Operating | 61,993 |
| Cash from Investing | -50,601 |
| Cash from Financing | 23,415 |
| Cash & Equivalent Yr End | 111,272 |